(SNK) Stomil Sanok - Ratings and Ratios
Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock • ISIN: PLSTLSK00016
SNK: Rubber, Springs, Dampers, Seals, Belts, Gaskets, Pharmaceuticals
Sanok Rubber Company Spólka Akcyjna, formerly known as Stomil Sanok S.A., is a Poland-based manufacturer specializing in rubber and polymer products. Established in 1932, the company has a long-standing history in producing a diverse range of components for various industries. Its product portfolio includes automotive parts such as springs, dampers, stabilizer bar links, and sealing systems, as well as rubber compounds for polymers. Additionally, the company serves the pharmaceutical sector by providing essential medical supplies like antibiotics and disposable syringes. Sanok Rubber Company also offers solutions for household appliances, including rubber bumpers and sealing profiles.
The companys operations extend beyond manufacturing, with a strong focus on laboratory research services to support product development and innovation. This commitment to R&D underscores its position as a key player in the automotive and industrial sectors. Sanok Rubber Companys strategic diversification across multiple industries has allowed it to maintain a stable market presence, adapting to evolving demands in both automotive and pharmaceutical markets.
From a technical perspective, SNK shares have shown a steady upward trend, with the 20-day SMA crossing above the 50-day SMA. The stock is currently trading near its SMA 20 of 22.97, with an ATR of 0.52 indicating moderate volatility. The recent price action suggests potential for further upside, supported by the bullish SMA crossover.
Fundamentally, the companys market cap of 575.66M PLN and P/E ratio of 9.26 indicate a reasonable valuation relative to earnings. The P/B ratio of 0.99 suggests that the stock is trading close to its book value, potentially offering value for long-term investors. The return on equity (RoE) of 10.87% highlights the companys ability to generate profits from shareholders equity.
3-Month Forecast: Based on the current technical and fundamental data, SNK shares are expected to maintain their upward trajectory, with potential resistance at 24.50 PLN and support at 21.80 PLN. The stock may experience short-term corrections but is likely to remain stable, driven by consistent earnings and industrial demand. Investors should monitor volume trends and broader market conditions for additional cues.
Additional Sources for SNK Stock
SNK Stock Overview
Market Cap in USD | 149m |
Sector | Consumer Cyclical |
Industry | Auto Parts |
GiC Sub-Industry | Automotive Parts & Equipment |
IPO / Inception |
SNK Stock Ratings
Growth 5y | 57.8% |
Fundamental | 15.6% |
Dividend | 60.5% |
Rel. Strength Industry | -5.1 |
Analysts | - |
Fair Price Momentum | 23.62 PLN |
Fair Price DCF | 31.57 PLN |
SNK Dividends
Dividend Yield 12m | 5.55% |
Yield on Cost 5y | 12.51% |
Annual Growth 5y | 4.66% |
Payout Consistency | 49.9% |
SNK Growth Ratios
Growth Correlation 3m | 83.7% |
Growth Correlation 12m | 44.9% |
Growth Correlation 5y | 45.9% |
CAGR 5y | 19.15% |
CAGR/Max DD 5y | 0.32 |
Sharpe Ratio 12m | -0.18 |
Alpha | -0.37 |
Beta | 0.48 |
Volatility | 18.41% |
Current Volume | 2.4k |
Average Volume 20d | 12.8k |
As of March 16, 2025, the stock is trading at PLN 23.00 with a total of 2,374 shares traded.
Over the past week, the price has changed by -0.22%, over one month by +0.00%, over three months by +12.75% and over the past year by +4.66%.
Neither. Based on ValueRay Fundamental Analyses, Stomil Sanok is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 15.57 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SNK as of March 2025 is 23.62. This means that SNK is currently overvalued and has a potential downside of 2.7%.
Stomil Sanok has no consensus analysts rating.
According to ValueRays Forecast Model, SNK Stomil Sanok will be worth about 25.5 in March 2026. The stock is currently trading at 23.00. This means that the stock has a potential upside of +10.91%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25.5 | 10.9% |